My Company Polska has selected the 25 hottest and best startups – and we’re among them! The stem-cell-based pharmaceuticals, which Bioceltix is developing, are a safer and more effective alternative to traditional chemical-based pharmaceuticals currently on the market. Bioceltix was established in 2016 – with its first funding coming from the StartitFund which is managed by Paweł Wielgus, PhD and Andrij Włach. The company currently employees 12 people. In May of this year, it was recognized at the Start-up Challenge in Katowice. Łukasz Bzdzion’s team was also among the 5 finalists of Chivas Venture.
